Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.
Patrick R. O'Neil, Executive Vice President, Chief Legal Officer & General Counsel of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), recently sold 6,165 shares of the company's common stock. The shares ...
Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease.